반응식
[Cl:1][C:2]1[N:3]=[N:4][C:5]([C:8]2[CH:13]=[CH:12][C:11]([C:14]#[N:15])=[CH:10][CH:9]=2)=[CH:6][CH:7]=1.[CH3:16][N:17]1[CH2:22][CH2:21][CH2:20][CH:19]([CH2:23][N:24]2[CH2:29][CH2:28][NH:27][CH2:26][CH2:25]2)[CH2:18]1>>[ClH:1].[ClH:1].[ClH:1].[CH3:16][N:17]1[CH2:22][CH2:21][CH2:20][CH:19]([CH2:23][N:24]2[CH2:29][CH2:28][N:27]([C:2]3[N:3]=[N:4][C:5]([C:8]4[CH:13]=[CH:12][C:11]([C:14]#[N:15])=[CH:10][CH:9]=4)=[CH:6][CH:7]=3)[CH2:26][CH2:25]2)[CH2:18]1참가 물질
3
실험 절차
The title compound was prepared by a similar procedure to that described in Example 1, starting from 3-chloro-6-(4-cyanophenyl)pyridazine and (1-methylpiperidin-3-ylmethyl)piperazine.
출처 및 근거
- ORD 기록
- ord-c11cc11fed5e42eabcaeb2e45826f10a
- 출처 데이터셋
- uspto-grants-2014_09
- 특허 번호
- US08846677B2
연결된 노트
불러오는 중…